DRAX EXAMETAZIME Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Drax Exametazime, and when can generic versions of Drax Exametazime launch?
Drax Exametazime is a drug marketed by Jubilant and is included in one NDA.
The generic ingredient in DRAX EXAMETAZIME is technetium tc-99m exametazime kit. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the technetium tc-99m exametazime kit profile page.
Summary for DRAX EXAMETAZIME
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in DRAX EXAMETAZIME? | DRAX EXAMETAZIME excipients list |
| DailyMed Link: | DRAX EXAMETAZIME at DailyMed |
Pharmacology for DRAX EXAMETAZIME
| Drug Class | Radioactive Diagnostic Agent |
| Mechanism of Action | Radiopharmaceutical Activity |
US Patents and Regulatory Information for DRAX EXAMETAZIME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jubilant | DRAX EXAMETAZIME | technetium tc-99m exametazime kit | POWDER;INTRAVENOUS | 208870-001 | Aug 17, 2017 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
